Novo Nordisk: Why the FDA Approval of the Wegovy Pill is the Starting Signal for the Stock!
Reading Time: 2 minutes
The stock of Novo Nordisk now offers the opportunity for a more pronounced recovery. On December 23, 2025, it received FDA approval for the Wegovy pill. What does this mean? The intake of a pill compared to the use of an injection expands the addressed market. An estimated 30% of young adults are afraid of needles. Additionally, the pills are very appealing for countries like India due to their lower costs and easier transportation/storage. Weight loss pills are significantly cheaper to produce and only need to be taken once daily. Furthermore,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

